Evaluation of Polyflex Stenting in Esophageal Cancer Patients

University of Louisville26 enrolled

Overview

To evaluate the effectiveness of an esophageal stent as a way to maintain nutrition during radiation and/or chemotherapy treatment.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Esophageal Cancer

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 years of age and older * Willing and able to provide informed consent * Willing to comply with follow-up requirements * Biopsy-confirmed esophageal cancer (adenocarcinoma or squamous cell carcinoma) in mid or distal esophagus (clinical stage 3 or less) * Indicated for chemotherapy and/or radiation therapy * Ability to dilate stricture to 15mm diameter at extent of disease evaluation * Placement of at least 18 x 23mm diameter and 120mm length PolyFlex stent Exclusion Criteria: * Patients contraindicated for endoscopy * Patients with prior esophageal stent placements * Advance stage of disease, greater than T3 tumor or M1 disease

Locations (1)

University of Louisville

Louisville, Kentucky, United States

Outcomes

Primary Outcomes

Clinical benefit of the Polyflex Esophageal Stent as a means to maintain oral nutrition during chemotherapy and/or radiation

Time frame: 8 - 10 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.